Claret Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.1M Buy
30,430
+101
+0.3% +$6.97K 0.27% 55
2025
Q1
$2.11M Buy
30,329
+117
+0.4% +$8.12K 0.3% 49
2024
Q4
$2.6M Buy
30,212
+22,921
+314% +$1.97M 0.41% 47
2024
Q3
$868K Hold
7,291
0.14% 74
2024
Q2
$1.04M Sell
7,291
-675
-8% -$96.4K 0.19% 64
2024
Q1
$1.02M Buy
7,966
+650
+9% +$83.5K 0.17% 67
2023
Q4
$757K Hold
7,316
0.14% 79
2023
Q3
$665K Buy
7,316
+66
+0.9% +$6K 0.13% 77
2023
Q2
$587K Hold
7,250
0.11% 85
2023
Q1
$577K Hold
7,250
0.11% 89
2022
Q4
$491K Hold
7,250
0.11% 92
2022
Q3
$361K Hold
7,250
0.09% 98
2022
Q2
$404K Hold
7,250
0.09% 101
2022
Q1
$403K Hold
7,250
0.08% 103
2021
Q4
$406K Sell
7,250
-72
-1% -$4.03K 0.08% 112
2021
Q3
$351K Hold
7,322
0.06% 124
2021
Q2
$307K Hold
7,322
0.05% 141
2021
Q1
$247K Hold
7,322
0.05% 151
2020
Q4
$256K Sell
7,322
-616
-8% -$21.5K 0.05% 148
2020
Q3
$276K Hold
7,938
0.06% 136
2020
Q2
$260K Sell
7,938
-7,980
-50% -$261K 0.06% 138
2020
Q1
$479K Sell
15,918
-3,410
-18% -$103K 0.14% 88
2019
Q4
$559K Sell
19,328
-138
-0.7% -$3.99K 0.11% 103
2019
Q3
$503K Sell
19,466
-94
-0.5% -$2.43K 0.1% 103
2019
Q2
$499K Hold
19,560
0.1% 106
2019
Q1
$512K Buy
19,560
+94
+0.5% +$2.46K 0.1% 104
2018
Q4
$448K Hold
19,466
0.1% 108
2018
Q3
$459K Buy
19,466
+1,808
+10% +$42.6K 0.09% 114
2018
Q2
$407K Buy
17,658
+9,000
+104% +$207K 0.08% 115
2018
Q1
$213K Hold
8,658
0.05% 143
2017
Q4
$232K Buy
+8,658
New +$232K 0.05% 140